Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03020095
What this trial is testing

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 38
Not applicableStudy completedNCT00705666
What this trial is testing

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepacivirus
Merck Sharp & Dohme LLC 789
Not applicableEnrolling By InvitationNCT07298577
What this trial is testing

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Who this might be right for
Liver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more
Siriraj Hospital 2,100
Large-scale testing (Phase 3)Study completedNCT03995485
What this trial is testing

KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Kawin Technology Share-holding Co., Ltd. 371
Post-approval studies (Phase 4)Ended earlyNCT00209898
What this trial is testing

Hepatitis C Treatment of Inmates

Who this might be right for
Chronic Hepatitis C
Haukeland University Hospital 42
Not applicableUnknownNCT05401136
What this trial is testing

Evaluating the Chain of Addiction Care (CAC)

Who this might be right for
Hepatitis C, ChronicSubstance Use Disorders
Radboud University Medical Center 1,000
Testing effectiveness (Phase 2)Study completedNCT01974687
What this trial is testing

Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 178
Early research (Phase 1)Study completedNCT02063607
What this trial is testing

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Large-scale testing (Phase 3)Study completedNCT02442271
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 222
Not applicableStudy completedNCT02505243
What this trial is testing

Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens

Who this might be right for
HCV CoinfectionHepatitis C
Radboud University Medical Center 252
Testing effectiveness (Phase 2)Study completedNCT00561015
What this trial is testing

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 52
Testing effectiveness (Phase 2)Study completedNCT02583685
What this trial is testing

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 138
Testing effectiveness (Phase 2)Study completedNCT02118012
What this trial is testing

Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT03740230
What this trial is testing

An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

Who this might be right for
Hepatitis C
AbbVie 3,134
Early research (Phase 1)Study completedNCT00959933
What this trial is testing

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

Who this might be right for
Chronic Hepatitis C
Sandoz 24
Post-approval studies (Phase 4)Study completedNCT00707850
What this trial is testing

Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection

Who this might be right for
Hepatitis CThalassemia
Baqiyatallah Medical Sciences University 300
Testing effectiveness (Phase 2)Study completedNCT02340962
What this trial is testing

Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
TaiGen Biotechnology Co., Ltd. 25
Not applicableStudy completedNCT02583243
What this trial is testing

Project BEST: Buprenorphine Entry Into Substance Abuse Treatment

Who this might be right for
Opioid-related DisordersHIV InfectionsHepatitis C, Chronic+1 more
Yale University 209
Not applicableStudy completedNCT02760355
What this trial is testing

Extrahepatic Insulin Resistance in Chronic Hepatitis C

Who this might be right for
Insulin Resistance
University Hospital, Geneva 17
Testing effectiveness (Phase 2)Study completedNCT01849562
What this trial is testing

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

Who this might be right for
Hepatitis C, Chronic
Alexion Pharmaceuticals, Inc. 30
Next Page